Onconetix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 62%.

Top 25 shareholders own 0% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0%	Altos Venture AG	2,695,931	€0	9,670%	no data
0%	Scablis Ag	581,938	€0	0%	no data
0%	New Horizon Health Limited	573,080	€0	0%	no data
0%	Ralph Schiess	495,903	€0	7,250%	no data
0%	Christian Bruhlmann	433,910	€0	7,250%	no data
0%	American Money Management Corporation	36,023	€0	0%	0.04%
0%	CincyTechUSA, Investment Arm	20,152	€0	0%	no data
0%	Cetera Investment Advisers LLC	8,000	€0	0%	no data
0%	ZKB Asset Management	7,651	€0	0%	no data
0%	Bank of America Corporation, Asset Management Arm	3,128	€0	0.1%	no data
0%	Susquehanna International Group, LLP, Asset Management Arm	2,842	€0	0%	no data
0%	Hudson River Trading LLC, Asset Management Arm	2,614	€0	0%	no data
0%	Jon Garfield	2,500	€0	0%	no data
0%	ClearArc Capital, Inc.	2,404	€0	0%	no data
0%	Geode Capital Management, LLC	2,381	€0	79.4%	no data
0%	Jane Street Group, LLC, Asset Management Arm	2,175	€0	0%	no data
0%	The Vanguard Group, Inc.	1,837	€0	0%	no data
0%	BlackRock, Inc.	1,339	€0	0%	no data
0%	State Street Global Advisors, Inc.	957	€0	0%	no data
0%	Bahl & Gaynor, Inc.	867	€0	0%	no data
0%	Baader Bank AG, Asset Management Arm	687	€0	0%	no data
0%	XTX Holdings Limited, Asset Management Arm	443	€0	0%	no data
0%	Tower Research Capital Europe Limited	319	€0	52.6%	no data
0%	James Sapirstein	159	€0	-13.1%	no data
0%	Vuk Jemeric	159	€0	0%	no data